Activation of B-raf in non-malignant nevi predicts a novel tumor suppressor gene in melanoma (MAP kinase phosphatase).
Arbiser
Jack L
JL
Department of Dermatology and Emory Skin Disease Research Core Center, Emory University School of Medicine, Atlana, Georgia, USA.
D018797:Cell Cycle Proteins; D054638:Dual Specificity Phosphatase 1; D016147:Genes, Tumor Suppressor; D006801:Humans; D017874:Immediate-Early Proteins; D008545:Melanoma / Q000235:genetics*; D009154:Mutation; D009506:Nevus / Q000235:genetics*; D010749:Phosphoprotein Phosphatases; D054645:Protein Phosphatase 1; D017027:Protein Tyrosine Phosphatases / Q000235:genetics*; D019908:Proto-Oncogene Proteins c-raf / Q000235:genetics*
D018797:Cell Cycle Proteins; D017874:Immediate-Early Proteins; D019908:Proto-Oncogene Proteins c-raf; D010749:Phosphoprotein Phosphatases; D054645:Protein Phosphatase 1; C517019:DUSP1 protein, human; D054638:Dual Specificity Phosphatase 1; D017027:Protein Tyrosine Phosphatases